146
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Preparation and characterization of dicarboxylic acids salt of aripiprazole with enhanced physicochemical properties

, , , , , , & show all
Pages 455-463 | Received 04 Oct 2020, Accepted 08 Feb 2021, Published online: 03 Mar 2021

References

  • Abd EA, Salem HF, Ali AMA, Maher EM. 2015. Formulation and in-vitro evaluation of fast dissolving tablets containing a poorly soluble antipsychotic drug. Int J Drug Deliv Techol. 7(2):113–125.
  • Abilify® label. (n.d.) [Accessed 2021 January 10]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf.
  • Barakh Ali SF, Dharani S, Afrooz H, Khan MA, Mohamed EM, Kohli K, Rahman Z. 2019. Application of salt engineering to reduce/mask bitter taste of clindamycin. Drug Dev Ind Pharm. 45(12):1871–1878.
  • Braun DE, Gelbrich T, Kahlenberg V, Tessadri R, Wieser J, Griesser UJ. 2009. Conformational polymorphism in aripiprazole: preparation, stability and structure of five modifications. J Pharm Sci. 98(6):2010–2026.
  • Center of Drug Evaluation and Research. 2018. Regulatory classification of pharmaceutical co-crystals, guidance for industry. Food and Drug Administration, U.S. Department of Health and Human Services. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm%0Ahttps://www.fda.gov/media/81824/download.
  • David SE, Timmins P, Conway BR. 2012. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs. Drug Dev Ind Pharm. 38(1):93–103.
  • Dharani S, Barakh AS, Afrooz H, Khan MA, Rahman Z. 2019. univariate and multivariate models for determination of prasugrel base in the formulation of prasugrel hydrochloride using XRPD method. J Pharm Sci. 108(11):3575–3581.
  • Dharani S, Rahman Z, Barakh Ali SF, Afrooz H, Khan MA. 2018. Quantitative estimation of phenytoin sodium disproportionation in the formulations using vibration spectroscopies and multivariate methodologies. Int J Pharm. 539(1-2):65–74..
  • Grothe E, Meekes H, Vlieg E, Ter Horst JH, De Gelder R. 2016. Solvates, salts, and cocrystals: A proposal for a feasible classification system. Cryst Growth Des. 16(6):3237–3243.
  • Guerrieri P, Rumondor ACF, Li T, Taylor LS. 2010. Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts. AAPS PharmSciTech. 11(3):1212–1222.
  • Gupta D, Bhatia D, Dave V, Sutariya V, Gupta SV. 2018. Salts of therapeutic agents: chemical, physicochemical, and biological considerations. Molecules 23(7):1719–1716.
  • Hansen AR, Beyer KD. 2004. Experimentally determined thermochemical properties of the malonic acid/water system: implications for atmospheric aerosols. J Phys Chem A 108(16):3457–3466.
  • Kalepu S, Nekkanti V. 2015. Insoluble drug delivery strategies: Review of recent advances and business prospects. Acta Pharm Sin B. 5 (5):442–453.
  • Lara-Ochoa F, Espinosa-Pérez G. 2007. Cocrystals definitions. Supramol Chem. 19(8):553–557.
  • Łaszcz M, Witkowska A. 2016. Studies of phase transitions in the aripiprazole solid dosage form. J Pharm Biomed Anal. 117:298–303.
  • Lu Y, Miller JD. 2002. Carboxyl stretching vibrations of spontaneously adsorbed and lb-transferred calcium carboxylates as determined by FTIR internal reflection spectroscopy. J Colloid Interface Sci. 256(1):41–52.
  • Maçôas EMS, Fausto R, Lundell J, Pettersson M, Khriachtchev L, Räsänen M. 2001. A matrix isolation spectroscopic and quantum chemical study of fumaric and maleic acid. J Phys Chem A 105 (15):3922–3933.
  • Maher EM, Ali AMA, Salem HF, Abdelrahman AA. 2016. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids. Drug Deliv. 23(8):3088–3100.
  • Maleic acid registration dossier-European Chemical Agency. 2020. [accessed 2020 May 30] https://echa.europa.eu/registration-dossier/-/registered-dossier/15769/4/22.
  • Malonic acid registration dossier-European Chemical Agency. 2020. [accessed 2020 May 30]. https://echa.europa.eu/registration-dossier/-/registered-dossier/17333/4/9
  • Mandal S, Mukhopadhyay TK, Mandal N, Datta A. 2019. Hierarchical noncovalent interactions between molecules stabilize multicomponent cocrystals. Cryst Growth Des. 19(8):4802–4809.
  • Mandell DJ, Chorny I, Groban ES, Wong SE, Levine E, Rapp CS, Jacobson MP. 2007. Strengths of hydrogen bonds involving phosphorylated amino acid side chains. J Am Chem Soc. 129(4):820–827.
  • Mihajlovic T, Kachrimanis K, Graovac A, Djuric Z, Ibric S. 2012. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique. AAPS PharmSciTech. 13(2):623–631.
  • Molecular OF. 1968. Infrared and Raman. J Mol Spectrosc. 410:394–410.
  • New Zealand Data Sheet. 2009. New Zealand data sheet.
  • Nyasulu FW, Macklin J. 2006. Intermolecular and intramolecular forces: A general chemistry laboratory comparison of hydrogen bonding in maleic and fumaric acids. J Chem Educ. 83 (5):770–773.
  • Paulekuhn GS, Dressman JB, Saal C. 2007. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book Database. J Med Chem. 50(26):6665–6672.
  • Portell A, Barbas R, Font-Bardia M, Dalmases P, Prohens R, Puigjaner C. 2009. Ziprasidone malate, a new trimorphic salt with improved aqueous solubility. CrystEngComm 11(5):791–795.
  • Rahman Z, Dharani S, Barakh Ali SF, Nutan MTH, Khan MA. 2020. Effects of diluents on physical and chemical stability of phenytoin and phenytoin sodium. AAPS PharmSciTech. 21(3):1–14.
  • Rahman Z, Zidan AS, Samy R, Sayeed VA, Khan MA. 2012. Improvement of physicochemical properties of an antiepileptic drug by salt engineering. AAPS PharmSciTech 13(3):793–801.
  • Saini A, Chadha R, Gupta A, Singh P, Bhandari S, Khullar S, Mandal S, Jain DS. 2016. New conformational polymorph of hydrochlorothiazide with improved solubility. Pharm Dev Technol. 21(5):611–618.
  • Samie A, Desiraju GR, Banik M. 2017. Salts and cocrystals of the antidiabetic drugs gliclazide, tolbutamide, and glipizide: solubility enhancements through drug-coformer interactions. Cryst Growth Des. 17(5):2406–2417.
  • Sarveiya V, Templeton JF, Benson HAE. 2004. Ion-pairs of ibuprofen: Increased membrane diffusion. J Pharm Pharmacol. 56(6):717–724.
  • Serajuddin ATM. 2007. Salt formation to improve drug solubility. Adv Drug Deliv Rev. 59(7):603–616.
  • Siddiqui A, Rahman Z, Khan SR, Awotwe-Otoo D, Khan MA. 2014. Root cause evaluation of particulates in the lyophilized indomethacin sodium trihydrate plug for parenteral administration. Int J Pharm. 473(1-2):545–551.
  • Succinic acid registration dossier-European Chemical Agency. 2020. [Accessed 2020 May 30]. https://echa.europa.eu/registration-dossier/-/registered-dossier/15265/4/9.
  • Walkling WD, Reynolds BE, Fegely BJ, Janicki CA. 1983. Xilobam: effect of salt form on pharmaceutical properties. Drug Dev Ind Pharm. 9(5):809–819.
  • Windriyati YN, Sumirtapura YC, Pamudji JS. 2020. Comparative in vitro and in vivo evaluation of fenofibric acid as an antihyperlipidemic drug. Turk J Pharm Sci. 17(2):203–210.
  • Xu Y, Liu X, Lian R, Zheng S, Yin Z, Lu Y, Wu W. 2012. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization. Int J Pharm. 438(1-2):287–295.
  • Zakeri-Milani P, Islambulchilar Z, Majidpour F, Jannatabadi E, Lotfipour F, Valizadeh H. 2014. A study on enhanced intestinal permeability of clarithromycin nanoparticles. Braz J Pharm Sci. 50(1):121–129.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.